| ‘Temporary Plasticiser’: A novel solution to fabricate 3D printed patient-centred cardiovascular ‘Polypill’architectures BC Pereira, A Isreb, RT Forbes, F Dores, R Habashy, JB Petit, MA Alhnan, ... European Journal of Pharmaceutics and Biopharmaceutics 135, 94-103, 2019 | 222 | 2019 |
| On demand manufacturing of patient-specific liquid capsules via co-ordinated 3D printing and liquid dispensing TC Okwuosa, C Soares, V Gollwitzer, R Habashy, P Timmins, MA Alhnan European Journal of Pharmaceutical Sciences 118, 134-143, 2018 | 167 | 2018 |
| Embedded 3D printing of novel bespoke soft dosage form concept for pediatrics K Rycerz, KA Stepien, M Czapiewska, BT Arafat, R Habashy, A Isreb, ... Pharmaceutics 11 (12), 630, 2019 | 95 | 2019 |
| Solvent-free temperature-facilitated direct extrusion 3D printing for pharmaceuticals M Kuźmińska, BC Pereira, R Habashy, M Peak, M Isreb, TD Gough, ... International Journal of Pharmaceutics 598, 120305, 2021 | 44 | 2021 |
| Temperature and solvent facilitated extrusion based 3D printing for pharmaceuticals F Dores, M Kuźmińska, C Soares, M Bohus, LA Shervington, R Habashy, ... European Journal of Pharmaceutical Sciences 152, 105430, 2020 | 44 | 2020 |
| Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment TC Okwuosa, M Sadia, A Isreb, R Habashy, M Peak, MA Alhnan International journal of pharmaceutics 600, 120442, 2021 | 25 | 2021 |
| A novel natural GRAS-grade enteric coating for pharmaceutical and nutraceutical products M Khoder, V Schropp, S Zeitler, B Pereira, R Habashy, PG Royall, ... International Journal of Pharmaceutics 584, 119392, 2020 | 23 | 2020 |
| Towards point-of-care manufacturing and analysis of immediate-release 3D printed hydrocortisone tablets for the treatment of congenital adrenal hyperplasia TL Yang, M Stogiannari, S Janeczko, M Khoshan, Y Lin, A Isreb, ... International Journal of Pharmaceutics 642, 123072, 2023 | 22 | 2023 |
| Creating acceptable tablets 3D (CAT 3D): a feasibility study to evaluate the acceptability of 3D printed tablets in children and young people L Bracken, R Habashy, E McDonough, F Wilson, J Shakeshaft, U Ohia, ... Pharmaceutics 14 (3), 516, 2022 | 22 | 2022 |
| An innovative wax-based enteric coating for pharmaceutical and nutraceutical oral products R Habashy, M Khoder, S Zhang, B Pereira, M Bohus, JTW Wang, A Isreb, ... International Journal of Pharmaceutics 591, 119935, 2020 | 16 | 2020 |
| The use of near-infrared as process analytical technology (PAT) during 3D printing tablets at the point-of-care TL Yang, J Szewc, L Zhong, A Leonova, J Giebułtowicz, R Habashy, ... International Journal of Pharmaceutics 642, 123073, 2023 | 13 | 2023 |
| Embedded 3D Printing of Novel Bespoke Soft Dosage Form Concept for Pediatrics. Pharmaceutics. 2019; 11: 630 K Rycerz, KA Stepien, M Czapiewska, BT Arafat, R Habashy, A Isreb, ... | 3 | |
| A novel multilayer natural coating for fed-state gastric protection R Habashy, M Khoder, A Isreb, MA Alhnan Pharmaceutics 14 (2), 283, 2022 | 2 | 2022 |
| Creating acceptable tablets 3D (CAT 3D): a feasibility study to evaluate the acceptability of 3D printed tablets in children and young people. Pharmaceutics 2022; 14: 5161–15 L Bracken, R Habashy, E McDonough, F Wilson, J Shakeshaft, U Ohia, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 1 | 2022 |
| A Novel Multilayer Natural Coating for Fed-State Gastric Protection. Pharmaceutics 2022, 14, 283 R Habashy, M Khoder, A Isreb, MA Alhnan s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| SP8 Creating acceptable tablets 3D (CAT 3D): a feasibility study to evaluate the mouthfeel of 3D printed tablets in children and young people L Bracken, E McDonough, J Shakeshaft, F Wilson, U Ohia, MA Alhnan, ... Archives of Disease in Childhood 105 (9), e5-e5, 2020 | | 2020 |
